Nachrichten zur Precipio Inc. Aktie

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

…

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

…

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

…

Form 10-Q Precipio, Inc. For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Precipio Announces Q2-2023 Shareholder Update Call

Conference Call to be held on August 17, 2023 at 5:00 PM EST Conference Call to be held on August…

Precipio launches quantitative BCR-ABL 2.0 panel for patients with chronic myeloid leukemia

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Revenue growth and customer pipeline advance the Company towards breakeven Revenue growth and customer pipeline advance the Company towards breakeven...…

Form 8-K Precipio, Inc. For: Jun 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Precipio, Inc. For: Jun 07

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

NEW HAVEN, Conn., June 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced it…

Precipio GAAP EPS of -$0.13 misses by $0.02, revenue of $2.82M beats by $0.02M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Precipio Shares Growth Catalysts For HemeScreen

Q1 Results and catalysts show promising growth trajectory Q1 Results and catalysts show promising growth trajectory...…

Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division

Customers pathology services annual revenues expected to exceed $1.5M Customers pathology services annual revenues expected to exceed $1.5M...…

Precipio Signs Another HemeScreen™ Customer

Customers revenues expected at $750K at full capacity Customers revenues expected at $750K at full capacity...…

Precipio granted 180 day extension by Nasdaq to regain compliance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Precipio, Inc. For: Apr 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Precipio Granted 180-day Extension From NASDAQ To Regain Compliance

Extension will enable the Company to execute on its growth and advance toward breakeven Extension will enable the Company to…

Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined

Q1-2023 product revenues approximately $0.76M exceeded the $0.66M combined revenue of Q3+Q4 2022 Q1-2023 product revenues approximately $0.76M exceeded the…

Precipio files for $50M mixed shelf offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Precipio, Inc. For: Mar 29

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call

Conference Call to be held on Monday, April 3rd, 2023 at 5:00 PM ET Conference Call to be held on…

Precipio Ships First IV-Cell® Order to Major US Healthcare System

Products Division revenues begin to diversify beyond HemeScreen® Products Division revenues begin to diversify beyond HemeScreen®...…

CORRECTION -- Precipio continues to sign up and onboard HemeScreen™ customers

Conversion from sales funnels developed with distribution partners alongside direct sales points to continued accelerated growth Conversion from sales funnels…

Precipio continues to sign up and onboard HemeScreen™ customers

Conversion from sales funnels developed with distribution partners alongside direct sales points to continued accelerated growth Conversion from sales funnels…